Need I say more?

Walgreens (WAG) comments on Wal-Mart (WMT) “will put them out of business strategy” on the company conference call:

  • For the 291 drugs that Wal-Mart will sell for $4, the average co-pay at Walgreens is $5.30 and for Medicare Part D patients it’s only $3.18.
  • Wal-Mart’s program covers less than 300 generic medications while Walgreens pharmacies’ stock has about 1800 different generics.
  • Over the years, WAG’s convenience, locations, and services have proven to be bigger factors for its patients than a few dollars in price difference – the point I argued in this article

    Need I say more?

  • Vitaliy Katsenelson

    I am the CEO at Investment Management Associates, which is anything but your average investment firm. (Seriously, take a look.)

    I wrote two books on investing, which were published by John Wiley & Sons and have been translated into eight languages. (Even in Polish!)

    In a brief moment of senility, Forbes magazine called me “the new Benjamin Graham.” (They must have been impressed by the eloquence of the Polish translation.)

    Don't miss new articles

    We'll let you know when we publish new articles